within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CE10_BenzathinePhenoxymethylpenicilli;

model BenzathinePhenoxymethylpenicilli
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 3.6111111111111115e-06,
    adminDuration = 600,
    adminMass = 1200 / 1000000,
    adminCount = 1,
    Vd = 0.015,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>BenzathinePhenoxymethylpenicillin</td></tr><tr><td>ATC code:</td><td>J01CE10</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Benzathine phenoxymethylpenicillin is a long-acting penicillin antibiotic, consisting of phenoxymethylpenicillin (penicillin V) in combination with benzathine to provide an extended-release intramuscular formulation. It was used for prophylaxis and treatment of infections caused by penicillin-sensitive microorganisms, particularly in streptococcal infections, but is not widely marketed or clinically used today.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed pharmacokinetic data for benzathine phenoxymethylpenicillin in humans available. The following represents a theoretical estimate for adults after intramuscular administration (extrapolated from similar benzathine penicillin G and phenoxymethylpenicillin profiles).</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J01CE10 folded in (Drugs.ATC removed)</li><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end BenzathinePhenoxymethylpenicilli;
